TransMedics Group Inc

20 de out. de 2026, 20:01 UTC

TransMedics Group Inc is positioned to benefit from the Trump administration's proposed kidney care plan aimed at enhancing competition and innovation in kidney treatment.

16 de out. de 2026, 20:02 UTC

Transmedics Group Inc shares are declining, reversing a trend of higher daily closes that persisted since Thursday's close.

15 de out. de 2026, 19:46 UTC

Stifel projects Transmedics Group Inc. will report third-quarter revenue between $185 million and $190 million, exceeding the Street's estimate of $178 million.

14 de out. de 2026, 20:07 UTC

Transmedics Group Inc shares fell sharply, closing significantly lower compared to Tuesday's close and reaching a low around midday.

13 de out. de 2026, 20:02 UTC

Canaccord Genuity maintains Buy rating on TransMedics Group Inc while lowering price target to $94.00, reflecting ongoing confidence in the company's prospects.

9 de out. de 2026, 20:06 UTC

Transmedics Group Inc shares are declining, unable to sustain an early spike, and are currently positioned significantly below their 20-day moving average.

8 de out. de 2026, 20:07 UTC

Transmedics Group Inc shares declined sharply on Thursday, finishing notably lower and remaining substantially below their 20-day moving average.

7 de out. de 2026, 19:50 UTC

TransMedics Group Inc. advanced after Barclays initiated coverage with an Overweight rating and a $120 price target, despite earlier pulling back from a session high.

5 de out. de 2026, 20:06 UTC

Transmedics Group Inc shares rose following Piper Sandler's initiation of coverage with an "Overweight" rating and a $100 price target.

2 de out. de 2026, 20:07 UTC

Transmedics Group Inc is gaining amid a broader market rally, driven by falling U.S. Treasury yields and improved investor sentiment since Thursday's close.

1 de out. de 2026, 20:02 UTC

Transmedics Group Inc shares fell sharply, reversing a recent trend of higher daily closes amid a shift in the asset's performance.

30 de set. de 2026, 19:15 UTC

Transmedics Group Inc shares fell after an early rise, currently trading below the 20-day moving average and near the lower end of its one-month range.

29 de set. de 2026, 19:45 UTC

Transmedics Group Inc is trading higher, rebounding from an early dip, although it remains below its 20-day moving average and near the lower end of its one-month range.

25 de set. de 2026, 20:07 UTC

Transmedics Group Inc. shares rose following Canada's first Organ Care System heart transplant, expected to boost donor heart availability by 40%.

24 de set. de 2026, 20:07 UTC

Transmedics Group Inc shares fell sharply, continuing a downward trend from Wednesday and finishing significantly below its 20-day moving average.

23 de set. de 2026, 20:07 UTC

Transmedics Group Inc shares fell amid a broader market decline, despite reaffirming 2026 revenue guidance of $737 million to $757 million.

22 de set. de 2026, 19:15 UTC

Transmedics Group Inc. appointed Fernando Araujo as CFO and reaffirmed 2026 revenue guidance of $737M to $757M, with shares trading higher.

21 de set. de 2026, 20:06 UTC

Transmedics Group Inc is trading higher following validation from a federal agency and a $7.27M contract for liver recovery services from Veterans Integrated Service Network 4.

18 de set. de 2026, 20:06 UTC

Transmedics Group Inc shares fell, closing below Thursday's level after fluctuating throughout the day, marking three consecutive sessions of lower closes.

17 de set. de 2026, 20:07 UTC

Transmedics Group Inc shares fell Thursday, declining from Wednesday's close despite a brief earlier rebound, amid overall lower market performance.

16 de set. de 2026, 20:10 UTC

Transmedics Group Inc shares fell modestly amid a broader market decline, stabilizing near the midpoint of its one-month range.

15 de set. de 2026, 20:07 UTC

TransMedics Group shares are rising following an insider purchase by Director David Weill at $81.63, amid positive social media discussions about the company.

14 de set. de 2026, 20:03 UTC

TransMedics Group Inc shares are gaining during Monday's session, despite earlier pullbacks. Broader market volatility is influenced by rising crude oil prices and inflation concerns.

11 de set. de 2026, 20:02 UTC

TransMedics Group Inc shares are lower following the announcement of a CFO transition. The company reaffirmed its 2026 revenue guidance of $737 million to $757 million.

10 de set. de 2026, 20:06 UTC

Transmedics Group Inc shares are lower amid broader market pressure, reflecting ongoing concerns over rising Treasury yields and inflation. No specific company news was identified.

9 de set. de 2026, 20:07 UTC

Transmedics Group Inc shares are lower today, breaking a recent trend despite positive sentiment reported by Jefferies' Transplant Tracker earlier this month.

8 de set. de 2026, 19:56 UTC

Transmedics Group reported EPS of $0.44 but lowered its adjusted operating margin guidance, contributing to a decline in shares since Friday's close.

4 de set. de 2026, 20:07 UTC

Transmedics Group reported Q2 EPS of $0.44, missing estimates. The company raised its 2026 revenue outlook, boosting investor sentiment and shares during Friday's session.

2 de set. de 2026, 19:56 UTC

Transmedics Group Inc shares are trading higher today, reflecting notable intraday volatility amid rising U.S. Treasury yields and broader market fluctuations.

1 de set. de 2026, 20:09 UTC

Transmedics Group Inc shares declined during Tuesday's session, reaching a low before a slight recovery. The stock remains below its 20-day moving average.